Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Standard processing takes 510 business days
doi:10.1038/ncomms9918 63
Its prevalence is estimated to increase to 1.02 billion by 2030 [1]
At Ascend Medical, we believe in integrating advanced therapies like GLP-1 medications into personalized care plans with comprehensive support that includes nutrition guidance, activity planning, and long term health monitoring
Related EMARKETER reports: Methodology: Data is from the Febraury 2025 Dentsu report titled "GLP-1s: Impact on Consumer Categories" conducted by Toluna
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 25.39
US$ 22.52
US$ 20.78
US$ 20.75
US$ 21.45
